Targeting Neuroinflammation
Treat Brain Disease

Founders of MindImmune Therapeutics, Inc. meet with Governor Raimondo at the Statehouse on Thursday, January 12, 2017

From left to right: Brian Campbell, VP Pharmacology, Stevin Zorn, President and CEO, Rhode Island Governor Gina Raimondo, Frank Menniti, Chief Science Officer, and Robert Nelson, VP Exploratory Biology